Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi setting.
Journal: Journal of geriatric oncology
Published: September 26, 2025
Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 06, 2025
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 13, 2023
Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 23, 2022
Impact of early detection on cancer curability: A modified Delphi panel study.
Journal: PloS one
Published: May 24, 2022
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.
Journal: Immunotherapy
Published: May 11, 2022
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Journal: Targeted oncology
Published: November 12, 2020
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Journal: Targeted oncology
Published: October 12, 2020
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Journal: The oncologist
Published: February 10, 2020
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.
Journal: American journal of hematology
Published: June 13, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026